PURE Bioscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2024 | 117.0% | 117.0% | -409.5% |
| FY2025 | 46.9% | 46.9% | -226.7% |
| FY2026 | 38.8% | -1,223.2% | -208.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2024 | 117.0% | 117.0% | -409.5% |
| FY2025 | 46.9% | 46.9% | -226.7% |
| FY2026 | 38.8% | -1,223.2% | -208.1% |